Eve Bender is a Health Editor at Medscape. With decades of experience in medical journalism, she specializes in topics such as psychiatry, mental health care, prenatal care, and remote healthcare. Eve's work has been featured in Medscape and MDEdge, showcasing her commitment to delivering insightful health-related content.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Eve Bender's coverage heavily relies on data citations, suggesting a preference for evidence-based insights and research-backed information. She appears to focus primarily on mental health and healthcare topics such as psychiatry, PTSD, depression, and neurology.
Given her reliance on data, pitches to Eve should emphasize scientifically backed insights or new findings in the field of mental health. Sources with access to relevant studies or clinical trials may be particularly appealing.
Since no specific geographic focus is indicated, it seems that Eve may cover global developments in mental health and healthcare rather than focusing on a particular region.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Sturgis Hospital said it could not find a sustainable path forward after years of declining reimbursement, rising costs and falling patient use.
The combined company will pair ChartSpan's care management services with Validic's device-data infrastructure to support remote patient monitoring and chronic care management.
Housing investments have supported more than 40,000 units as payers and providers look beyond medical care to reduce avoidable utilization and improve outcomes, the insurer says.
The collaboration gives LillyDirect customers access to a free Oura Ring sizing kit and connects Lilly's medication-access platform with Oura's wearable-based GLP-1 support tools.
The insurer says two former Maryland brokers enrolled out-of-state and overseas clients in health plans reserved for Maryland residents, generating more than 19,000 claims.
The health system will evaluate Signal 1's AI Management Platform to centralize governance, performance monitoring and ROI tracking across various AI-based tools.
The financing will help TISSIUM bring its FDA-authorized sutureless nerve repair product to the U.S. market and advance its broader tissue reconstruction platform.
The Series C, led by Menlo Ventures, pushed Assort to a $1.2 billion valuation and will support its expansion from voice AI into broader health system operations.
Optum is in talks with New York health systems to sell some orthopedic, general surgery and urology services.
By: Eve Bender
The investigational First Read tool analyzes chest X-rays and drafts preliminary report text for radiologist review and aims to relieve imaging demand strains.
